In clinical studies, 11.1% of patients discontinued treatment because of changes in their bleeding.
Information for patients about progestin-only birth control
- NEXPLANON is a progestin-only birth control and works primarily by suppressing ovulation, increasing cervical mucous viscosity, and alterations in the endometrium.
- Users of progestin-only contraceptives are likely to have changes in bleeding patterns.1
- These may include changes in bleeding frequency (absent, less, more frequent, or continuous), intensity (reduced or increased), or duration.1
Based on data from clinical trials of IMPLANON® (etonogestrel implant) non-radiopaque
- Patients who use NEXPLANON are likely to have changes in their vaginal bleeding patterns. These may include changes in bleeding frequency, intensity, or duration, or amenorrhea.
- For many patients, the bleeding pattern experienced during the first 3 months of using NEXPLANON is broadly predictive of the future bleeding pattern.
Percentages of 90-day intervals with these bleeding patterns during the first 2 years of use in clinical trials of IMPLANON*
- Frequent: >5 episodes
- Prolonged: Any episode lasting >14 days
- Amenorrhea: No episodes
- Infrequent: <3 episodes
Based on 3315 recording periods in 780 patients, excluding the first 90 days after implant insertion. Bleeding/spotting episode = one or more consecutive days during which bleeding or spotting occurred.2
Percentage of bleeding or spotting days based on data from clinical trials of IMPLANON® (etonogestrel implant) non-radiopaqueIn clinical trials of IMPLANON:
- Average number of days of spotting or bleeding: 17.7 every 90 days (N=780)
- Abnormal bleeding should be evaluated as needed to exclude pathologic conditions or pregnancy